A new standard of care for elderly patients with myeloma

Lancet. 2007 Oct 6;370(9594):1191-2. doi: 10.1016/S0140-6736(07)61522-0.
No abstract available

Publication types

  • Comment
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents, Alkylating / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Delivery of Health Care / standards*
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Melphalan / administration & dosage
  • Multiple Myeloma / drug therapy*
  • Multiple Myeloma / mortality
  • Prednisone / administration & dosage
  • Stem Cell Transplantation
  • Survival Rate
  • Thalidomide / administration & dosage

Substances

  • Antineoplastic Agents, Alkylating
  • Immunosuppressive Agents
  • Thalidomide
  • Melphalan
  • Prednisone